Seerlinq - an intelligent solution for remote monitoring and management of heart failure patients
| Seerlinq is an innovative telemedicine solution for remote monitoring of cardiac patients failing. This non-invasive technology uses photoplethysmographic signal (PPG) analysis which enables the prediction of the deterioration of the health condition as early as two to three weeks before the onset of symptoms, which effectively prevents hospitalizations. The main benefits for doctors include the possibility of early adjustment treatments based on current data on the patient's condition, personalized patient management and reducing the number of planned visits and hospitalizations. It brings increased comfort and quality to patients of life and an active approach to one's own health. In addition, the service does not increase the administrative burden for doctors, as its implementation and technical support is fully provided by the Seerlinq team. Seerlinq solution so represents a new level of care for patients with heart failure, enabling physicians effective remote treatment management and improved clinical outcomes. |
Sign in to Autumn ITAPA 2024
Allan Böhm
Allan Böhm, MD, MSc, PhD, MBA, FESC, FJCS is an established Slovak cardiologist and scientist, known for his pioneering work in precision medicine. He is the founder and CEO of Premedix, a leading research organization and clinic in precision medicine, where he also serves as a scientist and practicing cardiologist. In 2022, he expanded his entrepreneurial ventures by founding Seerlinq, a med-tech startup specializing in the development of artificial intelligence algorithms for the diagnosis and remote monitoring of cardiovascular patients.
From 2015 to 2023, he worked as a cardiologist in the Department of Acute Cardiology at the National Institute of Cardiovascular Diseases. He expanded his academic education by completing MSc in Clin…
See more info about the speaker
